Tomasz Ożański
2PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Oct 27, 2023
The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience.Magdalena Olszewska-Szopa, Agnieszka Ożańska, Tomasz Ożański
|Aug 28, 2021
A pre-registered short-term forecasting study of COVID-19 in Germany and Poland during the second wave.J Bracher, D Wolffram, J Deuschel
Pageof 1
